Saturday, December 4, 2021
68.5 F
Fort Worth

Fort Worth firm to acquire specialized surgical device firm

🕐 2 min read

TPG Capital, the private equity fund of Fort Worth-based TPG, announced July 18 it has entered into a definitive agreement to purchase specialized surgical device firm Beaver-Visitec International from RoundTable Healthcare Partners

BVI is a leading global developer, manufacturer, and marketer of specialized surgical devices for the ophthalmic marketplace. The sale is expected to close during the third quarter. Terms of the transaction were not disclosed.

“TPG has a long history of partnering with leading companies in the healthcare sector that hold significant growth potential,” said Jeffrey Rhodes, Partner at TPG. “We’ve worked with a wide variety of companies, from blood transfusion therapies business Fenwal to drug maker Par Pharmaceutical, to discover and invest in new opportunities.”

BVI was created in 2010 through the combination of three separate ophthalmic product businesses from Becton Dickinson, Medtronic, and Aspen Surgical. The company operates two state-of-the-art manufacturing plants in Waltham, Massachusetts and Bidford in the United Kingdom. BVI brings together high-quality brands, including Beaver blades, Visitec cannulae and instruments, Merocel and Weck-Cel ophthalmic fluid management products, and Wet-Field Eraser electrosurgery products. These products serve a wide variety of ophthalmic surgeries, including cataract, refractive, oculoplastic, and vitreoretinal sub-specialty procedures.

Since 2007, TPG has invested more than $8 billion in its healthcare portfolio across the platform.

TPG’s healthcare investments have spanned disciplines and geographies around the world, including pharmaceutical services firms such as IMS, Quintiles and EnvisionRX; blood transfusion therapy and diagnostics manufacturers Fenwal and Immucor; orthopedic device company Biomet; providers across the globe such as Surgical Care Affiliates, IASIS, Parkway, Chindex and Manipal Hospitals; and pharmaceutical manufacturers Adare, Aptalis and Par Pharmaceutical.

Deutsche Bank Securities Inc., Guggenheim Securities LLC, RBC Capital Markets and UBS Investment Bank acted as financial advisors to TPG. UBS Investment Bank, Deutsche Bank Securities Inc., Antares Holdings and RBC Capital Markets provided committed financing to TPG. Ropes & Gray LLP served as legal counsel to TPG.

Robert Francis
Robert is a Fort Worth native and longtime editor of the Fort Worth Business Press. He is a former president of the local Society of Professional Journalists and was a freelancer for a variety of newspapers, weeklies and magazines, including American Way, BrandWeek and InformatonWeek. A graduate of TCU, Robert has held a variety of writing and editing positions at publications such as the Grand Prairie Daily News and InfoWorld. He is also a musician and playwright.

Related Articles


Our Digital Sponsors

Latest Articles

Fort Worth Business Press Logo
This advertisement will close in
Click here to continue to Fort Worth Business Press

Not ready to subscribe?

Try a few articles on us.

Enter your email address and we will give you access to three articles a month, to give us a try. You also get an opportunity to receive our newsletter with stories of the day.

This field is for validation purposes and should be left unchanged.

Get our email updates

Stay up-to-date with the issues, companies and people that matter most to business in the Fort Worth.

  • Restaurants
  • Technology
  • and more!

FWBP Morning Brief

FWBP 5@5

Weekend Newsletter

  • Banking & Finance
  • Culture
  • Real Estate